SCIKON INNOVATION, INC.

DURHAM, NC · Medtech · Private

SciFlow 1000 fluidic culture system for in vitro drug toxicity and safety testing

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · scikoninnovation.com

Sector: Medtech
Headquarters: DURHAM, NC
Latest Form D: $350K, Sep 2015
Total capital: $3M

Federal grants: $2.6M; 6 awards · 2015–2018; Rank in peer group#416 of 538
Private capital raised: $350K; 1 Form D · last Sep 2015; 134 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 4; 4 pending · first 2016; Rank in peer group#125 of 538

Capital timeline

Latest events

Sep 2018Federal grantHealth and Human S · Phase II · Standardization of a Fluidic In Vitro Exposure System for IVIVE Predictive Toxicity Data$219K
Sep 2017Federal grantHealth and Human S · Phase II · Standardization of a Fluidic In Vitro Exposure System for IVIVE Predictive Toxicity Data$1.6M
Sep 2017Federal grantHealth and Human S · Phase I · Microfluidic Biotool to Accurately Model Corrosive Chemical Exposures for Human$225K
Aug 2017Federal grantHealth and Human S · Phase I · 3D Multi-Organ Model Using Microfluidics to Mimic in vivo Compound Exposure$225K
Feb 2016Federal grantHealth and Human S · Phase I · Low Cost Microphysiological System for Improved Pharmacodynamics$200K
Sep 2015Private capital raisedForm D · SEC · 1st filing$350K
Jun 2015Federal grantHealth and Human S · Phase I · Bench-top human metabolism system for improved IVIVE in drug development$169K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

3months

from SCIKON INNOVATION, INC.’s first federal award to its first private round.

First federal award · Jun 2015: Health and Human S · $169K
First Form D · Sep 2015: $350K · 1st Form D
Awards before first raise: 1 award

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

Federal grantsBelow median
Granted patents#125 · top 23%
Linked publications#63 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Randall E. McClellandResearcherExecutive Officer, DirectorLinked by 2 patents · $2.2M in grants as PI
Jodi E. KramerDirectorNamed in SEC Form D filings
Mike E. McCartneyDirectorNamed in SEC Form D filings
Steve E. PaladinoExecutive Officer, DirectorNamed in SEC Form D filings
Thomas E. MercolinoDirectorNamed in SEC Form D filings

What it has protected

USPTO · 4 granted of 8

Jul 31, 2018GrantedPiston assembly and related systems for use with a fluidics deviceUSPTOUS 10,035,145
Mar 1, 2018PendingMethod And Related Systems For Use With A Fluidics DeviceUSPTOApplication 15792845
Nov 28, 2017GrantedMethod And Related Systems For Use With A Fluidics DeviceUSPTOUS 9,829,499

Show all 8 patent records

Piston assembly and related systems for use with a fluidics deviceJul 31, 2018 · US 10,035,145Granted
Method And Related Systems For Use With A Fluidics DeviceMar 1, 2018 · Application 15792845Pending
Method And Related Systems For Use With A Fluidics DeviceNov 28, 2017 · US 9,829,499Granted
Fluidics Device Allowing Fluid Flow Between A Plurality Of WellsFeb 21, 2017 · US 9,573,128Granted
Basket for use with a fluidics deviceNov 17, 2016 · Application 15183755Pending
Assay Tray AssemblySep 27, 2016 · US D,767,783Granted
Method And Related Systems For Controlling Fluid Flow In A Fluidics DeviceApplication 62308207Pending
A Method And Related Systems For Use With A Fluidics DeviceApplication PCTUS2016023844Pending

Recent research by its founders

Rapid Detection of Direct Compound Toxicity and Trailing Detection of Indirect Cell Metabolite Toxicity in a 96-Well Fluidic Culture Device for Cell-Based Screening Environments: Tactics in Six Sigma Quality Control Charts20228 cites
A Unidirectional 96-Well Fluidic Culture Platform for Upstream Cell Dosing with Subsequent Downstream Nonlinear and Ascending Exposure Gradients for Real-Time and Cell-Based Toxicity Screening Environments20211 cites
Ex Vivo Conditions for Self-Replication of Human Hepatic Stem Cells20205 cites

MicroStructure Imaging, Inc.Similar federal contract value in Medtech · null in contracts
ENDOTHEIA INCSimilar federal contract value in Medtech · null in contracts
GYNION, LLCSimilar federal contract value in Medtech · null in contracts
TGen Tech, LLCSimilar federal contract value in Medtech · null in contracts
DIATECH DIABETES, INC.Similar federal contract value in Medtech · null in contracts
VON MEDICAL, INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.